Return to Home Mortality > Table > Interpret

Interpretation of Death Rates Data

Death Rate Report by State

All Cancer Sites, 2019-2023

All Races (includes Hispanic), Both Sexes, Ages <50

Sorted by Rate

Explanation of Column Headers

Death Rate (95% Confidence Interval) - The death rate is based upon 100,000 people and is for 5 year(s). Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population (the Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal).

Recent Trends - This is an interpretation of the AAPC:

AAPC (95% Confidence Interval) - The Average Annual Percent Change is the change in rate over time. These AAPCs are based upon APCs that were calculated by Joinpoint Regression Program


Other Notes


Line by Line Interpretation of the Report


Colorado


Massachusetts


District of Columbia


Connecticut


Rhode Island


New Jersey


Idaho


Utah


Montana


Wyoming


New Hampshire


Alaska


Minnesota


Washington


Wisconsin


Oregon


New York


North Dakota


California


Iowa


South Dakota


Vermont


Maryland


Virginia


New Mexico


Nebraska


Hawaii


Pennsylvania


Nevada


Illinois


Maine


North Carolina


Arizona


Puerto Rico


Texas


Georgia


Florida


Kansas


Michigan


Delaware


Missouri


Ohio


South Carolina


Indiana


Louisiana


Alabama


Tennessee


Oklahoma


Arkansas


Kentucky


West Virginia


Mississippi





Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 5:27 pm.

State Cancer Registries may provide more current or more local data.

† Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (20 age groups: <1, 1-4, 5-9, ... , 80-84, 85-89, 90+).

Population counts for denominators are based on Census populations as modified by NCI.

The US Population Data File is used with mortality data.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.